7 completed, 2 unknown, 1 enrolling by invitation, 1 not yet recruiting. 6 Phase 1, 2 Not applicable, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 5, Unknown 1 |
| Not applicable | 2 | Not yet recruiting 1, Unknown 1 |
| Phase 3 | 1 | Enrolling by invitation 1 |
| Phase 4 | 1 | Completed 1 |
Follow Eva Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adhesion and Safety of Rotigexole Compared to Neupro® Rotigexole 8 mg, Neupro ® 8 mg - Idiopathic Parkinson Disease | Not applicable | Not yet recruiting | Eva Pharma | 40 | 2025-09-01 | 2025-08-07 |
| Alpha Lipoic Acid in Pediatrics on Hemodialysis Alpha lipoic acid, Placebo - Hemodialysis Complication, Pediatric Kidney Disease | Phase 3 | Enrolling by invitation | Ain Shams University | 50 | 2025-02-02 | 2026-03-02 |
| Bioequivalence Study of of Metformin HCl From Gleptomet 50/1000 mg F.C.Tablets (EVA Pharma, Egypt) and Janumet 50/1000 mg F.C.Tablets (Merck Sharp & Dohme, The Netherlands) Gleptomet 50/1000(Metformin HCl & Sitagliptin), Janumet 50/1000(Metformin HCl & Sitagliptin) - Healthy | Phase 1 | Completed | Genuine Research Center, Egypt | 30 | 2022-11-29 | 2023-04-05 |
| Phase IV Trial to Evaluate Efficacy of Alpha-Lipoic Acid in Treating Symptomatic Diabetic Polyneuropathy in Egypt Alpha-Lipoic Acid (ALA), Placebo - Polyneuropathy, Diabetic | Phase 4 | Completed | Eva Pharma | 430 | 2022-10-26 | 2025-03-25 |
| Bioequivalence Study of Nirmatrelvir & Ritonavir From Copaxid 150 +100 mg Tablets (Eva Pharma, Egypt) Versus Paxlovid 150 + 100 mg Film Coated Tablets (Pfizer Europe, Belgium) Nirmatrelvir 150 mg + Ritonavir 100 mg (Reference first dose), Nirmatrelvir 150 mg + Ritonavir 100 mg (test), Nirmatrelvir 150 mg + Ritonavir 100 mg (Reference second dose) - Healthy | Phase 1 | Completed | Genuine Research Center, Egypt | 28 | 2022-08-21 | 2023-01-18 |
| Safety and Immunogenicity Study of EgyVax Vaccine Candidate for Prophylaxis of COVID-19 Infection EgyVax Vaccine Candidate, Placebo - COVID-19 | Phase 1 | Unknown | Eva Pharma | 45 | 2022-02-06 | 2022-02-23 |
| Anti-diabetic Drugs and Fatty Liver Management Metformin - Fatty Liver, Nonalcoholic, Diabetes Mellitus, Type 2 | Not applicable | Unknown | Alexandria University | 120 | 2021-02-23 | 2022-01-18 |
| Bioequivalence Study of Ivermectin From Revemact 6 mg Tablets (Man. by EVA Pharma for Horus for Pharmaceutical Industries, Egypt) and Stromectol 2*3 mg Tablets (Merck Sharp & Dohme B.V., Haarlem, The Netherlands) Revemact, Stromectol (first dose), Stromectol (second dose) - Healthy | Phase 1 | Completed | Genuine Research Center, Egypt | 30 | 2021-01-28 | 2021-04-27 |
| Clinical Efficacy and Safety of Leflunomide in Egyptian Patients With Active Rheumatoid Arthritis Active Rheumatoid Arthritis | Completed | Eva Pharma | 398 | 2017-06-16 | 2020-06-30 | |
| Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany) Prevaglip (linagliptin), Trajenta (linagliptin) - Healthy | Phase 1 | Completed | Genuine Research Center, Egypt | 24 | 2016-02-01 | 2016-08-05 |
| Bioequivalence Study of Vildagliptin From Gliptus 50 mg Tablet (EVA Pharma, Egypt) and Galvus 50 mg Tablet (NOVARTIS PHARMA, GERMANY) Vildagliptin - Healthy | Phase 1 | Completed | Genuine Research Center, Egypt | 24 | 2014-02-01 | 2016-06-29 |
COVID-19 (1) · Diabetes Mellitus, Type 2 (1) · Diabetic Neuropathies (1) · Non-alcoholic Fatty Liver Disease (1) · Parkinson Disease (1)
Thioctic Acid (2) · Vildagliptin (2) · Ivermectin (1) · Linagliptin (1) · Liraglutide (1) · Metformin (1) · Ritonavir (1) · Sitagliptin Phosphate (1) · Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination (1) · Tablets (1) · empagliflozin (1) · nirmatrelvir (1) · nirmatrelvir and ritonavir drug combination (1) · rotigotine (1)
Egypt (10)
Ahmed Elshafeey, Ph.D. Pharma (5) · Adel Elsayed, MD (1) · Ali S Shalash, Dr. (1) · Hatem S Mohammed, Dr. (1) · Khaled ES El Hadidy, PhD (1) · Mahmoud Mohsen, Pharmacist (1) · Mohamed R Halawa, PhD (1) · Nabil AF El Kafrawy, PhD (1) · Samir H Assaad Khali, PhD (1)